CalciMedica, Inc. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported net loss was USD 34.36 million compared to USD 7.82 million a year ago. Basic loss per share from continuing operations was USD 7.66 compared to USD 111.16 a year ago.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5.38 USD | -0.37% | -1.82% | +88.11% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+88.11% | 57.78M | |
+10.27% | 115B | |
+11.57% | 106B | |
-5.97% | 24.69B | |
-1.60% | 21.97B | |
-5.20% | 19.27B | |
-11.10% | 17.56B | |
-39.36% | 17.32B | |
+5.44% | 14.03B | |
+32.93% | 12.13B |
- Stock Market
- Equities
- CALC Stock
- News CalciMedica, Inc.
- CalciMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023